Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G K Schwartz

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Seminars in Oncology|June 1, 1996
Invasion and metastases in gastric cancer: in vitro and in vivo models with clinical correlationsG K Schwartz
Cancer Journal (Sudbury, Mass.)|October 19, 2000
Cyclin-dependent kinase and protein kinase C inhibitors: a novel class of antineoplastic agents in clinical developmentA Kaubisch, G K Schwartz
Oncology Research|January 1, 1997
Chemotherapeutically induced DNA damage, ATP depletion, and the apoptotic biochemical cascadeD S Martin, G K Schwartz
Current Oncology (Toronto, Ont.)|April 17, 2009
Development of cell-cycle inhibitors for cancer therapyM A Dickson, G K Schwartz
Investigational New Drugs|January 1, 1995
A phase II trial of doxorubicin HCl Liposome Injection in patients with advanced pancreatic adenocarcinomaG K Schwartz, E S Casper
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Cell cycle-mediated drug resistance: an emerging concept in cancer therapyM A Shah, G K Schwartz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cellsM Motwani, X Li, G K Schwartz
European Journal of Cancer (Oxford, England : 1990)|January 25, 2000
Raltitrexed (Tomudex) in combination with 5-fluorouracil for the treatment of patients with advanced colorectal cancer: preliminary results from phase I clinical trialsG K Schwartz, A Harstrick, M González Barón
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent mannerC T Hsueh, D Kelsen, G K Schwartz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cellsM Motwani, T M Delohery, G K Schwartz
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Seminars in Oncology|June 1, 1996
Invasion and metastases in gastric cancer: in vitro and in vivo models with clinical correlationsG K Schwartz
Cancer Journal (Sudbury, Mass.)|October 19, 2000
Cyclin-dependent kinase and protein kinase C inhibitors: a novel class of antineoplastic agents in clinical developmentA Kaubisch, G K Schwartz
Oncology Research|January 1, 1997
Chemotherapeutically induced DNA damage, ATP depletion, and the apoptotic biochemical cascadeD S Martin, G K Schwartz
Current Oncology (Toronto, Ont.)|April 17, 2009
Development of cell-cycle inhibitors for cancer therapyM A Dickson, G K Schwartz
Investigational New Drugs|January 1, 1995
A phase II trial of doxorubicin HCl Liposome Injection in patients with advanced pancreatic adenocarcinomaG K Schwartz, E S Casper
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Cell cycle-mediated drug resistance: an emerging concept in cancer therapyM A Shah, G K Schwartz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cellsM Motwani, X Li, G K Schwartz
European Journal of Cancer (Oxford, England : 1990)|January 25, 2000
Raltitrexed (Tomudex) in combination with 5-fluorouracil for the treatment of patients with advanced colorectal cancer: preliminary results from phase I clinical trialsG K Schwartz, A Harstrick, M González Barón
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent mannerC T Hsueh, D Kelsen, G K Schwartz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cellsM Motwani, T M Delohery, G K Schwartz
Pageof 7